<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01032213</url>
  </required_header>
  <id_info>
    <org_study_id>TEG/Mg</org_study_id>
    <nct_id>NCT01032213</nct_id>
  </id_info>
  <brief_title>Effect of Magnesium Sulphate on Coagulation</brief_title>
  <official_title>Effect of Magnesium Sulphate on Postoperative Coagulation as Measured by Thromboelastography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Arterial and venous thrombotic events are the clinical manifestation of postoperative
      hypercoagulability. Altered serum magnesium may play a role in the balance of coagulation. In
      this study, the investigators investigated the effect of magnesium sulphate on the
      postoperative coagulation change in total intravenous anesthesia (TIVA).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>thromboelastography (TEG) analysis</measure>
    <time_frame>twice</time_frame>
    <description>10 minutes before the induction of anesthesia
10 minutes after the recovery from the anesthesia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hemoglobin level</measure>
    <time_frame>twice</time_frame>
    <description>10 minutes before the induction of anesthesia
10 minutes after the recovery from the anesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>platelet count</measure>
    <time_frame>twice</time_frame>
    <description>10 minutes before the induction of anesthesia
10 minutes after the recovery from the anesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>international normalized ratio of prothrombin time (INR-PT)</measure>
    <time_frame>twice</time_frame>
    <description>10 minutes before the induction of anesthesia
10 minutes after the recovery from the anesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>activated partial thromboplastin time (aPTT)</measure>
    <time_frame>tiwce</time_frame>
    <description>10 minutes before the induction of anesthesia
10 minutes after the recovery from the anesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum magnesium level</measure>
    <time_frame>twice</time_frame>
    <description>10 minutes before the induction of anesthesia
10 minutes after the recovery from the anesthesia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Myoma</condition>
  <arm_group>
    <arm_group_label>group C</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>control group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group M</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>magnesium group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulfate</intervention_name>
    <description>Group M received 50 mg/kg of magnesium sulphate on 100 ml of isotonic saline over 10 minutes during the anesthesia induction, followed by the 15 mg/kg/h by continuous infusion during the operation</description>
    <arm_group_label>group M</arm_group_label>
    <other_name>magnesium sulphate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>Group S received the same volume of isotonic saline as same method.</description>
    <arm_group_label>group C</arm_group_label>
    <other_name>isotonic saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA Ⅰ-Ⅱ patients undergoing pelviscopic gynecologic operation under general
             anesthesia.

        Exclusion Criteria:

          -  Pregnancy

          -  Previous known hematologic disorder

          -  Recent medication interfering with hemostasis

          -  Severe anemia

          -  Liver disease

          -  Cardiovascular or respiratory disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2009</study_first_submitted>
  <study_first_submitted_qc>December 14, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2009</study_first_posted>
  <last_update_submitted>August 22, 2013</last_update_submitted>
  <last_update_submitted_qc>August 22, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 26, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Hyo-Seok Na</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

